CATALIS Québec is a non-profit organization whose governance relies on a network of public and private partners to carry out its mission and vision of operational improvement and excellence in clinical research in Quebec. The Advisory Committee plays an advisory role by supporting the executive management team in implementing the strategic plan and any priority actions approved by the board of directors.

Board of Directors

Marc Rivière MD

General Partner & CMO,
TVM Capital Life Sciences

Diane Gosselin PhD, MBA, ASC

President & CEO

Monique Lacroix

Country Head, Global Development Operations / Trial Monitoring
Novartis Pharmaceuticals Canada Inc.

Jefferson Tea PhD, MBA

Vice-President, Medical & Scientific Affairs
Takeda Canada Inc.

Jacques Michaud MD

Centre de recherche CHU Ste-Justine

Louise Proulx PhD, ICD.D

Corporate Director

Micheal Sebag

Michael Sebag MD

Research Institute – McGill University Health Centre (RI-MUHC)

Observer Members

Martin Doyon ing. PhD

Director, Networking and Industrial Partner Direction
Ministry of the Economy and Innovation of Quebec

Julie Couture

Director of Data Quality, Research and Internal Coordination
Minister of Health and Social Services (MSSS)


François Painchaud

Corporate Secretary
Partner, Robic

Domenic De Luca

Treasurer, Vice-President Finance and Assistant Corporate Secretary
President Managesco Inc.

Advisory Committee

Josée LeclercM.Sc., DESS

Senior Manager, Clinical Research
University of Montreal Hospital Research Centre (CRCHUM)

Cinzia Raponi CPA, CMA

Director, Administration
Research Institute McGill University Health Centre (MUHC)

Sylvie Cossette CPA, CA

Associate Director of Research
CHU Sainte-Justine

Annie Morin PhD

Interim Assistant Scientific Director
Centre de recherche du CHUS (CRCHUS) CIUSSS de l’Estrie – CHUS

Stéphane Bolduc MD FRCSC

Deputy-Director of clinical research
CHU de Québec – Université Laval

Chantal Lacasse PhD

Senior Clinical Operations Manager, Clinical Research
AbbVie Corporation

Pascale Landry PhD

Senior Clinical Research Associate, Clinical Research, Global Medical Division
GSK Canada

Jacqueline Atallah B.Pharm.

Director Clinical Site Management

Marie-France Goyer

Therapeutic Area Head, Merck

Jefferson Tea PhD, MBA

Vice-President, Medical & Scientific Affairs
Takeda Canada Inc.

Lucie d’AmoursB.A.A.

General Manager, Q-CROC

George Memari B.Sc.

Budget and Contract Manager

David Senac Eng.

Country Study Manager, Country Clinical Operations
Hoffmann-La Roche Limited (Roche Canada)

Dominique Johnson PhD

General Manager, McPeak Sirois

Danika Laberge PMP

General Manager

Observer Members

Martin Doyon ing. PhD

Director, Networking and Industrial Partner Direction
Ministry of the Economy and Innovation of Quebec

Vanessa Claveau B.Sc., MBA

Director, Life Sciences and Foreign Investment
Ministry of the Economy and Innovation of Quebec

Management team

Jacques Hendlisz

Jacques Hendlisz

Executive President of CATALIS Québec
Jacques Hendlisz is widely recognized for his extensive experience in the management of both research and hospital facilities. He served as the Douglas Institute’s Director General from 1994 to 2011 and as Director of Operations of the Goodman Cancer Research Centre from 2011 to 2012. Since 2003, Mr. Hendlisz has served on numerous boards of directors such as those of the McGill Centre for the Convergence of Health and Economics, Research Canada, the Ludmer Foundation, the Graham Boeckh Foundation, and the Fonds de recherche Québec – Santé (FRQS) (from 2004 to 2010). He is currently Chairman of the MNI’s Clinical Research Unit’s Advisory Board.  Jacques is committed and determined to gather all the actors involved in clinical research to accelerate the development of innovative patient care.

Danika Laberge PMP

General Manager of CATALIS Québec
Danika Laberge has over twenty years of experience working in the biopharmaceutical industry and in institutional settings. As a senior project manager with Project Management Professional (PMP) accreditation, she has headed numerous projects, including the Quebec CARTaGENE biobank, where she was the director of clinical operations. Between 2010 and 2017, Danika was in charge of operations at the McConnell Centre for Innovative Medicine at the Research Institute of the McGill University Health Centre, a centre specializing in clinical trial management. Danika Laberge helps CATALIS achieve its desired objectives by means of her thorough knowledge of the Quebec clinical research environment, her approach focused on operational excellence, her leadership and her qualities as a manager able to motivate actors in the life science industry.